• Profile
Close

Predicting prognosis of post-chemotherapy patients with resected IIIA non-small cell lung cancer

Journal of Thoracic Disease Aug 05, 2018

Zheng D, et al. - Researchers performed this retrospective analysis to develop nomograms for predicting the recurrence and survival of post-chemotherapy patients with resected IIIA non-small cell lung cancer (NSCLC). They analyzed their database from October 2007 to May 2013 at Fudan University Shanghai Cancer Center. They selected prognostic factors by performing univariable and multivariable analyses of cox regression. They developed nomograms for recurrence-free survival and overall survival. Based on the findings, they concluded that these nomograms could serve as a tool to make estimation of prognosis easier and could have utility for the selection of optimal decisions in clinical practices.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay